首页> 外文OA文献 >4,5-Di-substituted benzyl-imidazol-2-substituted amines as the structure template for the design and synthesis of reversal agents against P-gp-mediated multidrug resistance breast cancer cells
【2h】

4,5-Di-substituted benzyl-imidazol-2-substituted amines as the structure template for the design and synthesis of reversal agents against P-gp-mediated multidrug resistance breast cancer cells

机译:4,5-二取代的苄基-咪唑-2-取代的胺作为结构模板,用于设计和合成针对P-gp介导的多药耐药性乳腺癌细胞的逆转剂

摘要

Over-expression of P-glycoprotein (P-gp), a primary multidrug transporter which is located in plasma membranes, plays a major role in the multidrug resistance (MDR) of cytotoxic chemotherapy. Naamidines are a class of marine imidazole alkaloids isolated from Leucetta and Clathrina sponges, possessing a Y-shaped scaffold. Based on the results previously obtained from the third-generation MDR modulator ONT-093 and other modulators developed in our group, we designed and synthesized a series of novel 4,5-di-substituted benzyl-1-methyl-1H-imidazol-2-substituted amines using the Naamidine scaffold as the structure template. Subsequently, their reversing activity for Taxol resistance has been evaluated in P-gp-mediated multidrug resistance breast cancer cell line MDA435/LCC6MDR. Compounds 12c with a Y-shaped scaffold, and compound 17c which is 'X-shaped' scaffold and possesses a 4-diethylamino group at aryl ring B, turned out to be the most potent P-gp modulators. It appears that compounds 12c and 17c at 1 mu M concentration can sensitize LCC6MDR cells toward Taxol by 26.4 and 24.5 folds, with an EC50 212.5 and 210.5 nM, respectively. These two compounds are about 5-6 folds more potent than verapamil (RF = 4.5). Moreover, compounds 12c and 17c did not exhibit obvious cytotoxicity in either cancer cell lines or normal mouse fibroblast cell lines. This study has demonstrated that the synthetic Naamidine analogues can be potentially employed as effective, safe modulators for the P-gp-mediated drug resistance cancer cells.
机译:P-糖蛋白(P-gp)的过表达是一种主要的多药转运蛋白,位于质膜上,在细胞毒性化学疗法的多药耐药性(MDR)中起主要作用。 am啶是从Leucetta和Clathrina海绵中分离出来的一类海洋咪唑生物碱,具有Y形支架。基于先前从第三代MDR调节剂ONT-093和我们小组中开发的其他调节剂获得的结果,我们设计并合成了一系列新颖的4,5-二取代苄基-1-甲基-1H-咪唑-2 the胺骨架作为结构模板的取代胺。随后,已在P-gp介导的多药耐药乳腺癌细胞系MDA435 / LCC6MDR中评估了它们对紫杉醇耐药的逆转活性。具有Y形支架的化合物12c和“ X形”支架并且在芳环B上具有4-二乙基氨基的化合物17c被证明是最有效的P-gp调节剂。看来,浓度为1μM的化合物12c和17c可使LCC6MDR细胞对紫杉醇的敏感性提高26.4倍和24.5倍,EC50分别为212.5和210.5 nM。这两种化合物的效力比维拉帕米高约5-6倍(RF = 4.5)。此外,化合物12c和17c在癌细胞系或正常小鼠成纤维细胞系中均未表现出明显的细胞毒性。这项研究表明,合成的Na胺类似物可以潜在地用作P-gp介导的耐药性癌细胞的有效,安全的调节剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号